Two drugs being evaluated by the FDA slowed the development of treatment resistance in persons with metastatic malignant melanoma positive for the BRAF protein.

http://www.oncologynurseadvisor.com/dual-drug-therapy-delayed-treatment-resistance-in-melanoma/article/264688/http://www.oncologynurseadvisor.com/dual-drug-therapy-delayed-treatment-resistance-in-melanoma/article/264688/